Cargando…
Involvement of pro-inflammation signal pathway in inhibitory effects of rapamycin on oxaliplatin-induced neuropathic pain
BACKGROUND: Oxaliplatin is a third-generation chemotherapeutic agent that is commonly used to treat metastatic digestive tumors; however, one of the main limiting complications of oxaliplatin is painful peripheral neuropathy. The purpose of this study was to examine the underlying mechanisms by whic...
Autores principales: | Duan, Zongsheng, Su, Zhenbo, Wang, Hushan, Pang, Xiaochuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898663/ https://www.ncbi.nlm.nih.gov/pubmed/29587559 http://dx.doi.org/10.1177/1744806918769426 |
Ejemplares similares
-
Inhibition of microRNA-155 Reduces Neuropathic Pain During Chemotherapeutic Bortezomib via Engagement of Neuroinflammation
por: Duan, Zongsheng, et al.
Publicado: (2020) -
Neuroinflammation and central PI3K/Akt/mTOR signal pathway contribute
to bone cancer pain
por: Zhang, Jian, et al.
Publicado: (2019) -
Involvement of Serotonergic System in Oxaliplatin-Induced Neuropathic Pain
por: Lee, Ji Hwan, et al.
Publicado: (2021) -
Participation of pro-inflammatory cytokines in neuropathic pain
evoked by chemotherapeutic oxaliplatin via central GABAergic
pathway
por: Xu, Dongsheng, et al.
Publicado: (2018) -
NFATc2-dependent epigenetic downregulation of the TSC2/Beclin-1 pathway is involved in neuropathic pain induced by oxaliplatin
por: Liu, Meng, et al.
Publicado: (2023)